Posted on September 14, 2018 by Sitemaster
Alicia Morgans, MD, MPH, is a medical oncologist who specializes in prostate cancer management at Northwestern University Feinberg School of Medicine in Chicago, Illinois, where she is an associate professor in the Division of Hematology/Oncology. She is also an editor of the Advanced Prostate Cancer Center of Excellence for the UroToday web site. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: awareness, cancer, Morgans, prostate | 14 Comments »
Posted on August 16, 2018 by Sitemaster
The answer to this question, some 70 to 80 years after we started to see if we could answer it, is still: “We haven’t got a clue.” But every so often people come up with a new or a revised hypothesis, and it can take years to work out whether each specific hypothesis is viable. … READ MORE …
Filed under: Uncategorized | Tagged: cancer, citrate, development, prolactin, prostate, testosterone, zinc | 3 Comments »
Posted on June 19, 2018 by Sitemaster
In a new article in the Journal of Urology, researchers at Johns Hopkins Medical Center in Baltimore have again expressed their opinion that it would be inappropriate to rename low-risk Gleason 6 disease as something other than “cancer”. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: cancer, IMPACT, not, opinion, terminology | 3 Comments »
Posted on May 15, 2018 by Sitemaster
“Getting off biopsy train in prostate cancer” is the title of the latest article by Howard Wolinsky (a long-time active active surveillance patient) on the MedPage Today web site. We recommend it to your attention. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk | Tagged: active, cancer, Diagnosis, Management, proactive, risk, surveillance | 13 Comments »
Posted on May 8, 2018 by Sitemaster
The following infographic was also issued today by the U.S. Preventive Services Task Force (USPSTF) and offers guidance as to the appropriateness of prostate cancer screening for an average, 55- to 69-year-old American male with no specific, known risk factors for prostate cancer: … READ MORE …
Filed under: Diagnosis, Risk | Tagged: cancer, infographic, prostate, risk, screening | 8 Comments »
Posted on December 14, 2017 by Sitemaster
Earlier this year the American Society for Clinical Oncology (ASCO) worked with the Harris Poll to put in place ASCO’s first annual National Cancer Opinion Survey. We thought many of our readers might be interested in the findings. … READ MORE …
Filed under: Uncategorized | Tagged: American, cancer, perception, public | Leave a comment »
Posted on January 6, 2017 by Sitemaster
A new article in the journal Urologic Oncology has highlighted an association between the occurrence of advanced bladder cancer and the related finding of prostate cancer among such patients who have their prostate removed along with their bladder at the time of initial surgery for the bladder cancer (i.e., a radical cystoprostatectomy). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: advanced, bladder, cancer, cystectomy, cystoprostatectomy, risk | 7 Comments »
